Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
Grigoris Gerotziafas, Professor of Hematology at the Faculty of Medicine, Sorbonne University, Paris, and Head of the Thrombosis Department at Tenon Hospital in Paris, shared an insightful post on LinkedIn:
“We are pleased to share the publication, led by Prof. Alfonso Tafur (Department of Medicine, Vascular Medicine, Endeavor Health, Evanston, Illinois, University of Chicago, USA), of an important article on “Extended anticoagulation in patients with cancer-associated venous thromboembolism.”
This work highlights the challenges and strategies for managing CAT in oncology care and underscores the impact of the API-CAT study on optimizing antithrombotic treatment for patients with cancer-associated thrombosis.
The article emphasizes the urgent need to establish dedicated cancer thrombosis clinics to support shared decision-making and provide tailored management for patients.
We are proud to contribute to this significant initiative in collaboration with:
- CaVITE Thrombosis Center, Centre de Recherche Saint-Antoine (CRSA), INSERM U938, Sorbonne University, Paris, France, and
- Center for Translational Research and Education, Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, Chicago, USA.
Together, we aim to bridge science and clinical practice, delivering patient-centered strategies that enhance diagnosis, treatment, and prognosis for individuals facing cancer-associated thrombosis.”
Read the full article here:
Article: Extended anticoagulation in patients with cancer-associated venous thromboembolism
Authors: Atefeh Ghorbanzadeh, Mateo Porres-Aguilar, Robert McBane, Grigoris Gerotziafas, Alfonso Tafur

Discover the latest developments in coagulation and thrombosis research with Hemostasis Today.
-
Jul 11, 2026, 19:56Louise St. Germain Bannon: A Fantastic Start to ISTH 2026 and the Future of Thrombosis Research
-
Jul 11, 2026, 19:38Lynn Kloeckner: Recognizing Kirsten Lacine’s Impact on the Stroke Survivor Journey
-
Jul 11, 2026, 19:19Rens De Groot: New Proteomic Evidence Reveals Early Hemolysis During ADAMTS13 Relapse in Immune TTP
-
Jul 11, 2026, 19:01Laurent Bertoletti: Honoring the Legacy of Guy Meyer and the INNOVTE Network at ISTH 2026
-
Jul 11, 2026, 18:53Pilar de la Rocha Mur: Why Trust Is the Most Valuable Currency in Clinical Research
-
Jul 11, 2026, 18:25First Pathogenic Deep-Intronic SERPINC1 Variant Identified in Hereditary Antithrombin Deficiency – JTH
-
Jul 11, 2026, 18:12Dianne E. van der Wal: A Thought-Provoking Discussion on Immunothrombosis at ISTH 2026
-
Jul 11, 2026, 16:07Louise St. Germain Bannon: Where Innovation Meets Collaboration at ISTH 2026
-
Jul 11, 2026, 15:22Cécile Denis: A Unique Opportunity for Emerging Hemostasis Leaders